UNITED
NATIONS

E


Economic and Social Council

Distr.
GENERAL

1223rd Meeting

15 March 2002


CND Res.45/1.Human immunodeficiency virus/acquired immunodeficiency syndrome in the context of drug abuse

 

The Commission on Narcotic Drugs,

Alarmed at the continuing spread of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) epidemic around the world,

Concerned that an estimated forty million people across the globe are infected with HIV,

Recalling the Universal Declaration of Human Rights,9 in particular article 25, which states that everyone has the right to a standard of living adequate for the health and well-being of himself and of his family, including food, clothing, housing and medical care and necessary social services,

Commending the twenty-sixth special session of the General Assembly, on HIV/AIDS, and noting the targets set in the Declaration of Commitment on HIV/AIDS,10

Reiterating the concerns of the General Assembly, reflected in the Declaration of Commitment on HIV/AIDS, that the global HIV/AIDS epidemic, through its devastating scale and impact, constitutes a global emergency and one of the most formidable challenges to human life and dignity, as well as to the effective enjoyment of human rights, which undermines social and economic development throughout the world and affects all levels of society-national, community, family and individual,10

Recognizing that effective prevention, care and treatment strategies require behavioural changes and increased availability of and non-discriminatory access to, inter alia, vaccines, condoms, microbicides, lubricants, sterile injecting equipment, drug therapy, including anti-retroviral therapy, diagnostics and related technologies, as well as increased research and development,

Noting that the heads of State and Government and representatives of States and Governments participating in the twenty -sixth special session of the General Assembly, in the Declaration of Commitment on HIV/AIDS, solemnly declared their commitment to address the HIV/AIDS crisis by taking action, inter alia, to ensure that HIV/AIDS issues are included on the agenda of all appropriate United Nations conferences and meetings,10

Recalling that, in the Declaration on the Guiding Principles of Drug Demand Reduction, it is stated that demand reduction policies should aim at preventing the use of drugs and at reducing the adverse consequences of drug abuse,11

1. Recognizes that the spread of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), hepatitis C and other bloodborne viruses is linked with drug use, in particular injecting drug use;

2. Expresses concern about the continuing escalation in the popularity of amphetamine-type stimulants and other substances of abuse, and recognizes that the use of those substances promotes risk-taking behaviours among users, which increase the likelihood of HIV/AIDS spreading;

3. Recalls that the Action Plan for the Implementation of the Declaration on the Guiding Principles of Drug Demand Reduction recognized that progress to reduce the demand for illicit drugs should be seen in the context of the need for programmes to reduce the demand for substances of abuse and that such programmes should promote health and social well-being among individuals, families and communities and should reduce the adverse consequences of drug abuse for the individual and for society as a whole; 12

4. Encourages Member States to implement and strengthen efforts to raise awareness about the links between drug use and the spread of HIV/AIDS, hepatitis C and other blood-borne viruses;

5. Also encourages Member States to strengthen efforts to reduce the demand for illicit drugs and to ensure that a comprehensive package of prevention, education, treatment and rehabilitation measures are accessible to all individuals who use and abuse illicit drugs, including those infected with HIV/AIDS, in accordance with the Declaration on the Guiding Principles of Drug Demand Reduction;

6. Further encourages Member States to consider the potential impact on the spread of HIV, hepatitis C and other blood-borne viruses when developing, implementing and evaluating policies and programmes for the reduction of illicit drug demand and supply and to implement measures that reduce or eliminate the need to share non-sterile injecting equipment;

7. Calls upon the international community, where possible, to provide assistance for HIV/AIDS prevention, care and treatment in developing countries on a grant basis;

8. Commends the efforts of the United Nations International Drug Control Programme in response to the global epidemic of HIV/AIDS, and encourages Member States, to the extent possible, to support its efforts to reduce the impact of HIV/AIDS around the world;

9. Encourages the United Nations International Drug Control Programme to work with other United Nations entities to play a role in promoting awareness of HIV/AIDS at the global,
regional, national and community levels;

10. Welcomes the participation of the Joint United Nations Programme on Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in the work of the Commission on Narcotic Drugs, and calls upon the United Nations International Drug Control Programme to continue to cooperate with the Joint United Nations Programme and other relevant United Nations entities in introducing and strengthening programmes to address HIV/AIDS;

11. Requests the Executive Director of the United Nations International Drug Control Programme to submit to it at its forty-sixth session a report on the progress made in the implementation of the present resolution.

1223rd  meeting
15 March 2002

9/ General Assembly resolution 217 A (III).

10/ General Assembly resolution S-26/2, annex.

11/ General Assembly resolution S-20/3, annex, para. 8 (b).

12/ General Assembly resolution 54/132, annex, para. 5.